MissionIR Articles
-
MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics(TM) Secures Florida Regulatory Clearance to Close Dura Medical Acquisition
NRx Pharmaceuticals (NASDAQ: NRXP), through its wholly owned subsidiary HOPE Therapeutics(TM), Inc., announced it has received final clearance from the Florida Agency for Health Care Administration to proceed with closing its acquisition of revenue-generating, EBITDA-positive Dura Medical LLC, pending customary conditions. Founded in 2018, Dura operates clinics on Florida’s west coast specializing in mental health…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures FDA Type C Meeting for AVERSA(TM) Fentanyl Abuse-Deterrent Patch
Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the U.S. Food and Drug Administration has granted a Type C Meeting on Sept. 18, 2025, to review Chemistry, Manufacturing, and Controls plans for its lead product, AVERSA(TM) Fentanyl. Developed in partnership with Kindeva, the patch integrates Nutriband’s abuse-deterrent technology with Kindeva’s FDA-approved fentanyl…
-
MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Featured in NetworkNewsAudio APR on AI Wearables Market Surge
Wearable Devices (NASDAQ: WLDS, WLDSW), a pioneer in AI-powered neural input technology, is spotlighted in the NetworkNewsAudio APR titled “Neural Tech Drives the Growth of the AI Wearables Market.” The editorial explores how WLDS is helping shape the $260 billion projected wearables market through innovations like its Mudra Link wristband and LMM platform, which enable…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Posts 42% YoY Revenue and Gross Profit Growth and Record Cash Position
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services, reported Q2 2025 revenue of $3.1 million, up 42% year-over-year, Q2 2025 gross profit of $2.0 million, up 42% year-over-year and ended the quarter with a record $819 million in cash following a successful $400 million At-the-market…
-
MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in NNW Editorial on Rare Disease Innovation
Soligenix (NASDAQ: SNGX) today announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators.” The article underscores the growing healthcare challenges of rare diseases among aging Americans and the urgent need for effective therapies. Soligenix is spotlighted for its HyBryte(TM) platform, a novel treatment for…
-
MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Expands Golf Cart Production to Vietnam to Boost Supply Chain and Meet Demand
Massimo Group (NASDAQ: MAMO) announced it will begin receiving deliveries of its new six-seater golf carts from a manufacturing partner in Vietnam, complementing production at its Garland, Texas facility. The Vietnam expansion supports supply chain diversification, improved lead times, and cost efficiencies. The feature-rich MVR4X model offers a 60km range, 48V motor, and advanced safety features,…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Launches Open-Source Toolkit for Quantum AI and Machine Learning
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has released a new suite of developer tools aimed at accelerating quantum artificial intelligence (AI) and machine learning (ML) innovation. The launch includes an open-source quantum AI developer toolkit and a demo that allows developers to integrate D-Wave’s quantum processors…
-
MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Expands Global Patent Protection for AI-Based Explosives Detection
Safe Pro Group (NASDAQ: SPAI), a leader in AI-powered defense solutions, announced the international publication of its patent applications in Australia, Israel, and Europe for its SpotlightAI(TM) explosives detection technology. The Company’s SPOTD system, capable of identifying over 150 explosive threats in drone imagery, is now protected under the Patent Cooperation Treaty in 47 jurisdictions.…
-
MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Announces $2.4 Million Warrant Inducement Transaction
Wearable Devices (NASDAQ: WLDS, WLDSW), an award-winning AI-based gesture control technology company, has entered a warrant inducement agreement with an existing institutional investor for the immediate exercise of warrants to purchase up to 1,661,000 ordinary shares at $1.45 per share, generating approximately $2.4 million in gross proceeds. In exchange, the investor will receive 3,322,000 new…
-
MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Launches AI-Powered Touchless Neural Control Project for Military Use
Wearable Devices (NASDAQ: WLDS, WLDSW), a developer of AI-powered touchless sensing wearables, announced the launch of a military-focused project to advance human-machine interface (HMI) technology. The initiative aims to deliver a neural control system enabling soldiers to operate tactical systems through intuitive gestures without physical contact. Powered by the company’s proprietary neural interface and AI-driven…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Subsidiary Starlight Therapeutics Cleared by FDA to Begin GBM Combination Trial
Lantern Pharma (NASDAQ: LTRN) announced that its wholly owned subsidiary, Starlight Therapeutics, has received FDA clearance for an Investigational New Drug (“IND”) application to initiate a Phase Ib/2a clinical trial of STAR-001 (LP-184) in combination with spironolactone for patients with glioblastoma multiforme (“GBM”) at first progression. The study will evaluate safety, tolerability and preliminary efficacy…
-
MissionIRNewsBreaks – Alliance Entertainment (NASDAQ: AENT) Elevates Seven Key Leaders to Senior VP Roles
Alliance Entertainment Holding Corp. (NASDAQ: AENT) has promoted seven seasoned executives to Senior Vice President roles across its sales, fulfillment, IT, finance, and legal departments. The move reflects the company’s focus on accelerating growth in licensed collectibles and physical media through operational efficiency, exclusive content expansion, and a scalable, capital-light fulfillment model. CEO Jeff Walker…
-
MissionIRNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Offers $7,500 Price Cut on Mullen ONE and THREE EVs Ahead of Incentive Deadline
Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced $7,500 in additional price adjustments for commercial customers purchasing existing inventory of its Mullen ONE and Mullen THREE EVs. With MSRPs now set at $27,000 and $61,000 respectively, the incentive—combined with a $7,500 Inflation Reduction Act credit for deliveries before September 30—positions both models as high-value…
-
MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Applauds FAA Proposal to Normalize BVLOS Drone Operations
Safe Pro Group (NASDAQ: SPAI), a leader in AI-powered defense and security solutions, welcomed the FAA’s proposed rules to streamline Beyond Visual Line of Sight (BVLOS) drone operations. The Company expects the move will accelerate adoption of its computer vision and object detection technologies across government, public, and commercial sectors. Safe Pro’s Airborne Response unit…
-
MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Secures Continuation Patent for Gesture and Voice-Control Interface
Wearable Devices (NASDAQ: WLDS, WLDSW), a technology company specializing in AI-powered touchless sensing wearables, announced the issuance of a continuation patent by the U.S. Patent and Trademark Office, expanding its foundational patent titled “Gesture and Voice-Controlled Interface Device.” The patent enhances protection for the company’s neural interface technologies by introducing a method to identify start…
-
MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has filed a Citizen Petition with the FDA requesting the removal of Benzethonium Chloride (BZT) from all ketamine products sold in the U.S. BZT, a quaternary amine preservative, is not Generally Recognized as Safe (GRAS) for parenteral use or Generally Recognized as Safe and Effective (GRASE) for…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Unveils AI Tool to Predict Blood-Brain Barrier Permeability with 94% Accuracy
Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology drug development company, has launched predictBBB.ai(TM), a public AI module that predicts blood-brain barrier (BBB) permeability of small molecules with 94% accuracy, 95% sensitivity, and 89% specificity. Built on billions of molecular data points from Lantern’s proprietary data lake, the platform addresses the pharmaceutical challenge that only 2–6%…
-
MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Achieves Biological Efficacy in Phase 2a SGX945 Study for Behçet’s Disease
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing products for rare diseases, has completed its Phase 2a proof of concept study evaluating SGX945 (dusquetide) in Behçet’s Disease, meeting the objective of demonstrating biological efficacy. In the open-label trial, SGX945 achieved a 40% improvement in the primary ulcer endpoint versus a historical placebo group from the…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Sets Standard in High-Performance E-Boat Space
- GlobalTech Corp. (GLTK) Weaves a Portfolio of AI-Powered Solutions That Are Revolutionizing Industries Like Sports, E-commerce, Education and Others
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Secures Multi-Million Dollar Resource Commitment from IBM (NYSE: IBM)
- SuperCom Ltd. (NASDAQ: SPCB) Expands European Presence with New $7 Million German Contract, Covering Multiple Programs
- Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development